Skip to content

Monofil

by Assut Europe SpA Italy EUDAMED

Ref FQ459F

EMDN H010101010301

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number8033439MONOFIL3T Basic UDI-DIDate8 Jun 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Not covered

European Union — CE/MDR Active

Certificates

2 certificates · EUDAMED

EUDAMED certificates (2)
  • CSQ0013236626 Supplemented

    Quality management system EU MDR

    Issued
    28 Sep 2026
    Expires
    7 Aug 2028
    Reason
    Add device or group
  • CVD0049250426 Supplemented

    Technical documentation EU MDR

    Issued
    28 Sep 2026
    Expires
    7 Aug 2028
    Reason
    Add device or group

Specification

EUDAMED · synced 24 Oct 2026

Model / Reference
FQ459F
Primary DI / UDI-DI
18033439455140
Basic UDI-DI
8033439MONOFIL3T
Direct Marketing DI
18033439455140
EMDN Code
H010101010301 Poliglecaprone and derivatives monofilament with needle
Device Class
Class III
Market of Registration
Italy

Manufacturer details

EUDAMED SRN
IT-MF-000018178

Other devices from Assut Europe SpA

See all devices from Assut Europe SpA →

Properties & raw data

Show properties, registry sources and raw records
  • Sterile
  • Implantable
Other properties (11)
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED 18033439455140|8033439MONOFIL3T 61 fields · synced 24 Oct 2026